CD45, panCK, and HER2 antibodies were used to distinguish the immune cell (CD45+), normal epithelium (panCK+, HER2−) and tumor cell (panCK+, HER2+) compartments (Figure 2A). The gene discussed is PTPRC; the disease is neoplasm.